| Entries |
| Document | Title | Date |
|---|
| 20080220088 | Composition for Treating Wounds and Burns - The invention discloses the use of a liquid composition, capable of promoting the growth of tissue cells at the site of a wound, a process that promotes regeneration of tissue and wound healing. More particularly, the present invention relates to the use of a liquid composition comprising a component (a) selected from the salts consisting of cations A | 09-11-2008 |
| 20080220089 | Medical agent for preventing or treating diseases resulting from one of inflammation and remodeling, and method for preventing or treating the diseases - An object of the present invention is to provide a medical agent that has an excellent effect on the diseases resulting from one of inflammation and remodeling and that can prevent or treat them in response to various mechanisms of onset and development of the diseases. Thus, the present invention relates to a medical agent for preventing or treating diseases resulting from one of inflammation and remodeling in blood vessel, including nanobubbles. | 09-11-2008 |
| 20080274206 | Stabilised Oxygen Releasing Composition - The present invention relates to stabilised liquid oxygen releasing composition comprising a component (a) selected from the salts consisting of cations A | 11-06-2008 |
| 20090011044 | OZONE CONTAINING PRODUCT PACKAGE - A product package is provided for containing a product or object. The package contains a first agent that is energizably convertible by an energy source to a sanitizing agent including ozone in the package. The sanitizing agent including ozone in the package is transferred to the product or object while in the package. The first agent can include oxygen. The oxygen converts to ozone after being energized by ultraviolet radiation energy inside the package. The ultraviolet radiation energy can be radiated from outside the package, through the package, and into the package to energizably convert the oxygen to ozone in the package. The product or object in the package can be treated with the sanitizing agent including ozone in the package to provide a sanitizing, disinfecting, or sterilizing treatment, in the package. | 01-08-2009 |
| 20090035386 | CONDITIONING OF A PATIENT'S BLOOD BY GASES - The present invention relates to a method for using gas exchange modules for adjusting a pH value of blood in order to, e.g., adjust a non-physiological pH in patients treated with drugs whose activity optimum is in a non-physiological pH or to bring the pH to a physiological value. | 02-05-2009 |
| 20090035387 | PROCESS FOR MAKING OZONIZED OLIVE OIL GEL AND THE GEL OBTAINED - A process for making oil which is rich in ozone in the form of a gel comprises the steps of introducing olive oil in liquid form and ozone into a reaction chamber; in which during the contact step there is a step of controlled cooling of the reaction chamber in controlled pressure conditions, until a stable gel has been formed. | 02-05-2009 |
| 20090053320 | Disease and Pest Control Agent Containing Dissolved Microbubles Consisting of Oxygen and Ozone - The present invention relates to systems and methods for producing disease and pest control agent for plants and crops containing dissolved oxygen and ozone. This present invention of disease and pest control agent for plants and crops containing dissolved microbubbles of oxygen and ozone consists of 0.3-40 μm pore size microbubbles of ozone (03) 1.0-10.0 volume % and oxygen (O2) 99.0-90.0 volume % dissolved in water as colloids and the concentration of ozone in this solution is 1˜30 mg/l. This invention produces disease and pest control agent for plants and crops that contains microbubbles consisting of highly concentrated oxygen and ozone dissolved in water as colloid which is environmentally friendly and highly effective as pesticidal and germicidal agent. | 02-26-2009 |
| 20090068282 | Use of metal complex compounds as oxidation catalysts - Use of metal complex compounds of formula | 03-12-2009 |
| 20090117202 | Formulations Containing a Non-Oxidative Biocide and a Source of Active Halogen and Use Thereof In Water Treatment - Novel formulations containing a non-oxidative biocide, such as DBNPA, and a source of an in situ produced active biocide, such as a concentrated aqueous solution of an inorganic halide salt, are disclosed. These novel formulations are particularly effective in the treatment of water, and are characterized by high stability, desirable rheological properties and an excellent biocidal activity. | 05-07-2009 |
| 20090258087 | Method to increase and accelerated rehabilitate the capacity for work - The method to increase and accelerated rehabilitate the capacity for work is characterized in that the person is exposed to gaseous products having the property to improve physical and psychological human capabilities during a period of preparing for extreme strains and/or after extreme strains; the exposure to gaseous products is performed during a period from several weeks to several minutes before undergoing extreme strains by inhaling the gaseous mixture composed of oxygen and/or air and at least one inert gas, mainly xenon, with the contents of oxygen or air from 20% to 98% and at least one inert gas from 2% to 80%. The inhalation with the gaseous mixture is carried out until the state of euphoria emerges but no longer than for 20 minutes with breaks or without them; preferably, the inhalation with the gaseous mixture is performed no less than for 10 seconds and no longer than for 20 minutes with breaks or without them. Permanent and accelerated rehabilitation of the organism's capabilities and work capacity improvement during preparatory periods for extreme strains and in the course of extreme stressful strains as well as prompt rehabilitation of the diminished organism after extreme physical strains is provided due to the impact of gaseous products, i.e. oxygen cocktails having the property to improve human physical and psychological abilities and relieve mental, emotional and physical strain, pain and tiredness. | 10-15-2009 |
| 20090263498 | Pharmaceutical preparations for treating inflammatory diseases - The present invention refers to a pharmaceutical preparation for treating inflammatory diseases and microbial infections comprising a pharmaceutically effective amount of ozone and at least one monomeric amino acid having an oxidation-sensitive side chain, or at least one ozonized monomeric amino acid having an oxidation-sensitive side chain. | 10-22-2009 |
| 20090304810 | Composition and method for enhanced sanitation and oxidation of aqueous systems - Compositions and methods for their use are presented that substantially increase the rate of inactivation of microbiological organisms, especially those resistant to inactivation from free halogen based sanitizers, and oxidation of oxidation resistant organic based compounds in aqueous solution. Aquatic facilities susceptible to accumulation of organic N-chloramines, cyanuric acid and other oxidation resistant compounds, as well as oxidation resistant parasitic organisms such as cryptosporidium and Giardia, obtain dramatic improvements in the rate of oxidation and subsequent inactivation of these undesirable contaminants | 12-10-2009 |
| 20100009009 | METHOD AND COMPOSITION FOR PREVENTION AND TREATMENT OF ORAL FUNGAL INFECTIONS - A composition of stabilized chlorine dioxide at a concentration range of about 0.0004% to about 0.8% (w/v) having anti fungal properties to prevent oral fungal infections and method of use are disclosed. | 01-14-2010 |
| 20100047362 | Method and Pharmaceutical Composition for Improvement of Wound Healing - This invention relates to aqueous solutions of reactive chlorine compounds having the empirical formulae H | 02-25-2010 |
| 20100151043 | PREPARATION FOR STERILIZATION OR DISINFECTION OF TISSUE - The present invention relates to a preparation for sterilizing or disinfecting a tissue which has an excellent tissue sterilizing or disinfecting ability and is suitable for therapeutic or prophylactic treatment of various diseases caused by a microorganism such as a bacterium or a virus and a method for sterilizing or disinfecting a tissue. The present invention relates to a preparation for sterilizing or disinfecting a tissue and an agent for therapeutic or prophylactic treatment of a periodontal disease, characterized by containing a gas in a nanobubble state. Furthermore, the present invention relates to the above-mentioned preparation for sterilizing or disinfecting a tissue, characterized in that the above-mentioned gas in a nanobubble state is ozone. Furthermore, the present invention relates to a liquid preparation for sterilizing or disinfecting a tissue, characterized by comprising ozone-nanobubble water. | 06-17-2010 |
| 20100178356 | Composition and method for enhanced sanitation and oxidation of aqueous systems - This invention relates to a method for enhanced sanitation and oxidation of aqueous solutions at aquatic facilities. The method provides a means for the in-situ generation of chlorine dioxide from dilute solutions of chlorite anions at near neutral pH, and enhanced inactivation rates of microbiological organisms including cryptosporidium. | 07-15-2010 |
| 20100183737 | GLASS FLAKE - The glass flake of the present invention has a composition that includes, in terms of mass %, 60| 07-22-2010 | |
| 20100189807 | Use of an ozone / oxygen mixture as a primary anticancer therapy via intraperitoneal insufflation - Head and neck squamous cell carcinomas (HNSCC) represent a group of metastasizing tumors with a high mortality rate in man and animals. Since the biomolecule ozone was found to inhibit growth of various carcinoma cells in vitro we here applied the highly aggressive and lethal VX2 carcinoma HNSCC tumor model of the New Zealand White rabbit to test whether ozone exerts anti-tumorous effects in vivo. Therapeutic insufflation of medical ozone/oxygen (O | 07-29-2010 |
| 20100196502 | Isoform Selective HDAC Inhibitors - One aspect of the invention relates to isoform-selective HDAC inhibitors. Also provided are methods of sensitizing a cancer cell to the cytotoxic effects of radiotherapy. The invention also provides methods for treating cancer, methods for treating neurological diseases and methods for treating malaria. Additionally, the invention provides pharmaceutical compositions comprising an HDAC inhibitor of the invention; and kits comprising a an HDAC inhibitor of the invention. | 08-05-2010 |
| 20100316730 | TREATMENT OF CARDIOVASCULAR DISEASES WITH OZONE - Methods of treating cardiovascular diseases, including atherosclerosis, peripheral arterial occlusive disease, congestive heart failure, hypertension, cerebrovascular disease, dyslipidemia and vasospastic disorders such as Raynaud's disease, in a mammalian patient involve extracorporeally subjecting an amount of blood, blood fractionate or other biological fluid from a patient to a measured amount of ozone delivered by an ozone delivery system, resulting in the absorption of a quantifiable absorbed-dose of ozone and reinfusing the treated fluid into the patient to therapeutically treat cardiovascular disease and related conditions. | 12-16-2010 |
| 20110008462 | SYSTEM AND METHOD FOR THERAPEUTIC APPLICATION OF DISSOLVED OXYGEN - A system and method for generating an oxygen enriched aqueous solution for therapeutic application includes a diffuser comprising a first diffusing member having a surface incorporating surface disturbances, and a second diffusing member positioned relative to the first diffusing member to form a channel through which an aqueous solution and oxygen gas may flow. A reservoir containing the aqueous solution is connected to a pump that draws the aqueous solution from the reservoir and inputs the aqueous solution into the diffuser. The aqueous solution is moved through the channel relative to the surface disturbances to create cavitation in the aqueous solution to diffuse the oxygen gas into the aqueous solution to produce an oxygen enriched aqueous solution. | 01-13-2011 |
| 20110045100 | Antimalarial Quinolines and Methods of Use Thereof - One aspect of the invention relates to substitute quinolines with antimalarial activity, and compositions and kits comprising at least one of them. Another aspect of the invention relates to methods for the treatment or prevention or both of malaria comprising administering to a subject a therapeutically effective amount of such a compound. Importantly, a number of the compounds show excellent potency against both chloroquine-sensitive and chloroquine-resistant strains. | 02-24-2011 |
| 20110064824 | METHOD FOR ENRICHING WATER WITH OXYGEN BY AN ELECTROLYTIC PROCESS, OXYGEN ENRICHED WATER OR BEVERAGE AND USES THEREOF - The invention relates to a method for enriching water with oxygen by an electrolytic process, that comprises the following series of steps: the electrolysis of Cl | 03-17-2011 |
| 20110200682 | Method of Healing - A method for treating a patient comprising: (a) injecting into the bloodstream of a patient is breathing a gas mixture having greater than 25% oxygen an aqueous solution comprising: 0.1 to 0.8 M Mg++ and having an osmolarlity less than about 1500 mOSm/l; | 08-18-2011 |
| 20110229583 | Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid - A medicinal drug is administered to a person for treating a medical condition of the person or/and for preventing the person from contracting the medical condition. The medical condition can be a bacterial infection, a eukaryotic infection, a prion-caused infection, a non-pathogenic inflammation, and, insofar as not covered by any of these four types of the medical condition, a fungal infection, a spore-caused infection, and a parasitic infection. A medicinal drug is similarly administered non-topically to a person for treating a virus-caused medical condition of the person or/and for preventing the person from contracting the virus-caused medical condition. The medicinal drug is typically formed at least partially with salt of peroxymonosulfuric acid, preferably potassium hydrogen peroxymonosulfate. | 09-22-2011 |
| 20110268816 | APPARATUSES AND SYSTEMS TO PROCESS A FLUID, AND METHODS FOR USING THE SAME - A method for oxygenating a fluid, the method including launching a sub-orbital lower-level apparatus to a predetermined altitude greater than 20,000 feet above sea level. The method also includes, at the predetermined altitude, actuating a fluid capture mechanism sealingly configured to collect and store an atmospheric fluid. In addition, returning the a sub-orbital lower-level apparatus to an altitude less than 20,000 feet, and introducing at least a portion of the atmospheric fluid to an oxygenation process to mix the captured atmospheric fluid with another fluid. | 11-03-2011 |
| 20120003325 | USE OF HELIUM-OXYGEN GAS MIXTURES FOR TREATING PULMONARY ARTERIAL HYPERTENSION - The present application relates to the use of helium-oxygen gas mixtures for the treatment and/or prophylaxis of primary and secondary forms of pulmonary hypertension (PH) and also to the combination of drugs and helium-oxygen gas mixtures, wherein the gas mixtures are used as carrier gases to improve the introduction of a drug for the treatment and/or prophylaxis of pulmonary hypertension. | 01-05-2012 |
| 20120128789 | USE OF XENON FOR TREATING HYPERSENSITIVITY TO PAIN - The invention relates to a gaseous mixture containing oxygen (O2) and a volume proportion of 20 to 70% of xenon (Xe) for use as an inhalable drug for preventing or treating hypersensitivity to pain in humans or animals, in particular hypersensitivity to pain expressed as hyperalgesia or allodynia. | 05-24-2012 |
| 20120156309 | Using Aqueous Oxygenation to Improve Animal Health & Wellness - Dispersing gas in a liquid provides a mixture of saturated, supersaturated or hypersaturated solution to provide a suspension of bubbles containing gas therein into which animal tissue is immersed for health or wellness treatment. A two-phase mixture is provided with dissolved gas as a suspension of microbubbles. Methods for making, maintaining, and using the two-phase mixture are provided. Gas molecules may be introduced into a liquid at high velocity under elevated pressure to form a supersaturated solution that retains the gas, preferably oxygen, in solution when exposed to ambient conditions. | 06-21-2012 |
| 20120189710 | ANTIBACTERIAL COMPOSITIONS - Compositions and their use for treating bacterial infections are described, in particular compositions for treating multi-species infections and the treatment of bacterial infections arising from biofilms. The present invention also relates to antibacterial compositions for treating dental diseases. Compositions of the present invention may include a garlic extract or S-allyl cysteine, and optionally an antibiotic and/or an antiseptic. | 07-26-2012 |
| 20120213863 | THERAPEUTIC GAS FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS - The use of gaseous oxygen for the production of a therapeutic gas for inhalation by a patient who has been identified as a person with a mitochondrial disorder or a coenzyme Q10 deficiency, for the treatment of mitochondrial disorders or Q10 deficiencies is disclosed. | 08-23-2012 |
| 20120225133 | USE OF AN AGENT THAT RESTORES TISSUE PERFUSION AND OXYGENATION - The presently disclosed subject matter provides methods for increasing perfusion in hypoxic regions of tissues in subjects. Also provided are methods for treating diseases and/or disorders associated with hypoxia in subjects, methods for increasing sensitivity of tumors to radiation and/or chemotherapy treatments, methods for delaying tumor growth in subjects, and methods for inhibiting tumor blood vessel growth in subjects. In some embodiments, the presently disclosed methods involve administering to subjects in need thereof a first composition selected from the group consisting of a nitrosylated hemoglobin and an agent that induces nitrosylation of endogenous hemoglobin in the subject and a second composition comprising a hyperoxic gas. In some embodiments, the presently disclosed methods also include treating a tumor with radiation therapy, chemotherapy, photodynamic therapy, immunotherapy, or combinations thereof. Also provided are inhalable gases that can be employed in the presently disclosed methods. | 09-06-2012 |
| 20120269898 | COMPOSITIONS AND METHODS OF TREATING PULMONARY HYPERTENSION - Provided are formulations comprising therapeutically effective amounts of ambrisentan or a pharmaceutically acceptable salt thereof and tadalafil or a pharmaceutically acceptable salt thereof and methods of treating and/or preventing pulmonary hypertension by administration of the formulations. | 10-25-2012 |
| 20120269899 | Method For Oxygen Treatment Of Intact Skin - Oxygen therapy for healthy or inflamed but intact skin involves placing an oxygen-generating dressing onto the skin to be treated, the oxygen-generating bandage being a one-time use dressing capable of generating oxygen for only a short period of time, not to exceed about 4 hours. | 10-25-2012 |
| 20130095192 | RESUSCITATION FLUID - A method for treating conditions related to lack of blood supply with a lipid based resuscitation fluid is disclosed. The resuscitation fluid contains a lipid component and an aqueous carrier. The lipid component forms an emulsion with the aqueous carrier. The resuscitation fluid can be used to increase the blood pressure and to carry oxygen to tissues. The resuscitation fluid can also be used for preserving the biological integrity of donor organs for transplantation. | 04-18-2013 |
| 20130136801 | Antimicrobial Composition Including a Residual Barrier Film - This disclosure describes example antimicrobial compositions that may be used in combination with IV port cleansing caps, protective caps, or nasal decolonizer devices. According to another implementations, the disclosure describes that the antimicrobial composition may provide an indication that it has come into contact with a contaminant by bubbling or foam on a surface that is being cleaned. According to another implementation, the disclosure describes that the antimicrobial composition may leave a residual film or barrier to inhibit the recontamination of a surface that has been cleaned. | 05-30-2013 |
| 20130177657 | METHOD AND ARRANGEMENT FOR GENERATING OXYGEN AND NITRIC OXIDE - The invention relates to a Method of generating oxygen and nitric oxide. The method comprises the steps of: guiding an oxygen comprising gas to a primary side of a dense membrane ( | 07-11-2013 |
| 20130209574 | OXYGEN TREATMENT OF WATER AND PULP FROM PAPER OR CARDBOARD PRODUCTION - Methods for treating water and pulp used in a paper or cardboard manufacturing process. Oxygen and nutrients are added to the water or pulp to increase the activity of aerobic bacteria resulting in a reduction of organic substances such as fatty acids. Alternatively oxygen alone is added to the water or pulp to reduce all both aerobic and anaerobic bacterial activity. | 08-15-2013 |
| 20130209575 | MULTI-PART KIT SYSTEM FOR THE PREPARATION OF A DISINFECTANT - A multi-part kit system comprising (i) a solid part A which comprises 10 to 80 wt. % of peroxy compound selected from the group consisting of KHSO | 08-15-2013 |
| 20130224306 | METHOD FOR TREATING A PULMONARY HYPERTENSION CONDITION WITHOUT COMPANION DIAGNOSIS - There is provided a method for treating pulmonary hypertension in a subject, comprising: administering to the subject in need thereof a daily dose of ambrisentan from 1 mg to about 15 mg, wherein the method is carried out without drug labeling instruction to monitor liver aminotransferase levels during ambrisentan treatment. | 08-29-2013 |
| 20130230602 | Devices and Methods for Making and Administering an Intravenous Liquid with Supersaturated Dissolved Gas - Methods and devices for treating patients using high partial pressures of dissolved gas in a liquid. Greater than hyperbaric partial pressures of gas may be dissolved and maintained in the liquid when mixing occurs at ambient pressure. Additional increases in dissolved gas partial pressure may be achieved when the temperature of the liquid is further decreased. The method further includes administering the liquid intravenously via a conventional catheter. Gas exchange occurs due to diffusion upon mixing of the liquid and blood within the vasculature of the patient. | 09-05-2013 |
| 20130236563 | METHODS OF AMELIORATING OXIDATIVE STRESS BY INCREASING THE EFFICIENCY OF GPX AND SOD ACTIVITY - Methods of ameliorating cellular oxidative stress are disclosed. | 09-12-2013 |
| 20140030356 | METHOD FOR TREATING A PULMONARY HYPERTENSION CONDITION WITHOUT COMPANION DIAGNOSIS - There is provided a method for treating pulmonary hypertension in a subject, comprising: administering to the subject in need thereof a daily dose of ambrisentan from 1 mg to about 15 mg, wherein the method is carried out without drug labeling instruction to monitor liver aminotransferase levels during ambrisentan treatment. | 01-30-2014 |
| 20140050800 | METHOD OF REDUCING OXIDATIVE STRESS - Methods of ameliorating cellular oxidative stress and reducing serum cholesterol are disclosed. | 02-20-2014 |
| 20140072653 | SYSTEM AND METHOD FOR GENERATION OF POINT OF USE REACTIVE OXYGEN SPECIES - Systems and methods for generating reactive oxygen species formulations useful in various oxidation applications. Exemplary formulations include singlet oxygen or superoxide and can also contain hydroxyl radicals or hydroperoxy radicals, among others. Formulations can contain other reactive species, including other radicals. Exemplary formulations containing peracids are activated to generate singlet oxygen. Exemplary formulations include those containing a mixture of superoxide and hydrogen peroxide. Exemplary formulations include those in which one or more components of the formulation are generated electrochemically. Formulations of the invention containing reactive oxygen species can be further activated to generate reactive oxygen species using activation chosen from a Fenton or Fenton-like catalyst, ultrasound, ultraviolet radiation or thermal activation. Exemplary applications of the formulations of the invention among others include: cleaning in place applications, water treatment, soil decontamination and flushing of well casings and water distribution pipes. | 03-13-2014 |
| 20140072654 | CANCER WITH METABOLIC THERAPY AND HYPERBARIC OXYGEN - The present invention demonstrates the therapeutic use of ketone esters for seizure disorders, Alzheimer's disease malignant brain cancer, and other cancers, which are associated with metabolic dysregulation. The administration of a ketogenic diet, such as ketone esters, while concurrently subjecting the patient to a hyperbaric, oxygen-enriched environment resulted in therapeutic ketosis. Optionally, the hyperbaric, oxygen-enriched environment is 100% oxygen at 2.5 ATA absolute. The ketone esters may be derived from acetoacetate and can include R,S-1,3-butanediol acetoacetate monoester, R,S-1,3-butanediol acetoacetate diester, or a combination of the two. The treatment may further include administering at least 10% ketone supplementation, such as acetoacetate, adenosine monophosphate kinase, 1,3-butanediol, or ketone ester, to the patient. | 03-13-2014 |
| 20140099384 | APPARATUS AND METHODS FOR PRODUCING OZONE - The invention relates to improvements in apparatus and methods for producing ozone. The apparatus comprises: a differential pressure injector, a means for circulating aqueous fluid through the differential pressure injector and programmable control means. An ozone generator is provided for connection to an oxygen source via an oxygen delivery conduit and a first valve means is located in the oxygen delivery conduit. The ozone generator is fluidly connected to the differential pressure injector via an ozone delivery conduit and second valve means are located in the ozone delivery conduit. Pressure monitoring means are located between the ozone generator and the first valve means for providing a pressure measurement to the control means. The valve means and the fluid circulation means are operable to create a negative pressure in the oxygen and ozone delivery conduits and the pressure measurement is used by the control means to determine the integrity of the oxygen and ozone delivery conduits. | 04-10-2014 |
| 20140199411 | THERAPEUTIC AGENT FOR EMPHYSEMA AND COPD - The invention described herein relates to methods of treating emphysema and COPD with a GHK tripeptide. The invention further relates to methods of determining the state of the lungs using biomarkers described herein. | 07-17-2014 |
| 20140271917 | CONTROLLED AND PREDICTABLE 2-PATH-WAY DECOMPOSITION OF THERMODYNAMICALLY DOUBLE UNSTABLE OXIDISING AGENTS - Disclosed herein is a method comprising: obtaining characteristics of a cleaning or disinfection application; querying a database comprising experimental relationships, theoretical relationships or both, between the characteristics of the cleaning or disinfection application and a composition; determining one or more compositions suitable for the cleaning or disinfection application based on the characteristics and the database. | 09-18-2014 |
| 20140302168 | Microbiocidal Solution with Ozone and Methods - A microbiocidal solution is provided that includes an electrolyzed saline solution, ozone, and active chlorine species producible via electrolysis that is usable to sanitize and disinfect a surface or substance. A method for producing a microbiocidal solution is provided that includes preparing a dilute saline solution and subjecting the dilute saline solution to electrolysis to produce an electrolyzed saline solution and active chlorine species and including ozone. A method also is provided for disinfecting a surface or substance using a microbiocidal solution where ozone disinfects via high oxidization properties and the active chlorine species provides a residual disinfectant effect. The microbiocidal solution may also include hydroxyl radicals and oxy-chloro species. | 10-09-2014 |
| 20150056296 | KIT FOR PREPARING CARBON-DIOXIDE-CONTAINING COMPOSITION - [Problem] The objective of the present invention is, in a kit that is for preparing a carbon-dioxide-containing composition containing an oxygen-containing gel composition and a carbonate-containing gel composition, to provide a formulation technology enabling uniform and easy mixing, uniform generation of carbon dioxide, and the prevention of dripping down when applied to skin. | 02-26-2015 |
| 20150099008 | ANTIMICROBIAL COMPOSITION - A composition that includes ethylhexyl sulfate or a salt thereof, an alkylbenzenesulfonic acid or a salt thereof, and a carrier. The ethylhexyl sulfate, or salt thereof, and the alkylbenzenesulfonic acid, or salt thereof, are present in a weight ratio of at least about 1:2. The composition can be used for killing or inhibiting a microorganism or pathogen (e.g., bacteria, gram-negative bacteria, gram-positive bacteria, enteric bacteria, virus, fungus, mold, mildew or powdery mildew). | 04-09-2015 |
| 20150125545 | AQUACULTURE WATER TREATMENT SYSTEMS AND METHODS - A water treatment device and methods of treating water such as in aquaculture systems, are described. The water treatment device utilizes oxygen containing air that is exposed to ultraviolet radiation and to a magnetic field to treat the water resulting in reduced and controlled | 05-07-2015 |
| 20150125546 | COMBINATION THERAPY FOR TREATING PULMONARY HYPERTENSION - Method of treating and/or preventing pulmonary arterial hypertension comprising administering effective amounts of ambrisentan or a pharmaceutically acceptable salt thereof and riociguat or a pharmaceutically acceptable salt thereof. | 05-07-2015 |
| 20150320791 | SYSTEMS AND METHODS TO IMPROVE ORGAN OR TISSUE FUNCTION AND ORGAN OR TISSUE TRANSPLANT LONGEVITY - The present invention provides for systems and methods for inhaled CO therapy to prevent, attenuate, or delay processes that accelerate the loss of organ or tissue function, thereby increasing the lifespan of transplanted organs or tissues, or slowing the decline of native organs or tissues, or delaying the need for replacement of diseased native organs with organ transplants. Such biological processes that are prevented, attenuated, or delayed include chronic persistent inflammation, fibrosis, scarring, as well as immunologic or autoimmune attack. | 11-12-2015 |
| 20150323550 | METHOD FOR THE DIAGNOSIS OF SYSTEMIC SCLERODERMA OR OF PULMONARY ARTERIAL HYPERTENSION - The invention relates to an in vitro method for detecting systemic scleroderma (SSc) and/or pulmonary arterial hypertension (PAH), or a risk of developing SSc or PAH, which comprises determining the presence and/or the amount of antibodies in a biological sample originating from a patient. | 11-12-2015 |
| 20150359818 | METHOD FOR PRODUCING A GAS TRANSPORTING RHEOLOGICAL MEDIUM - A method for producing a gas transporting rheological medium, said method comprises: (a) hydrating and dispersing a thickening agent in a fluid medium; (b) adding a first gas for dissolution and/or adsorption the fluid medium using a minimum fluid system pressure of about 7 psig; (c) mechanically emulsifying dimethylpolysiloxane into the fluid medium; (d) adding a source of one or more +2 valence cations to the suspension for 10 crosslinking to form a gel; and (e) dispensing the gel into a container. | 12-17-2015 |
| 20160175347 | METHODS FOR THE PRODUCTION OF COLLAGEN IV | 06-23-2016 |
| 20160198720 | VOLATILE DISINFECTANT AND METHOD FOR PRODUCING VOLATILE DISINFECTANT | 07-14-2016 |
